These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33219222)

  • 21. Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals.
    Coutinho LS; Honorato H; Higuchi CH; Cavalcante DA; Belangeiro S; Noto M; Bressan RA; Cordeiro Q; Noto C; Gadelha A
    Schizophr Res Cogn; 2019 Jun; 16():12-16. PubMed ID: 30581766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.
    Ochoa S; Usall J; Cobo J; Labad X; Kulkarni J
    Schizophr Res Treatment; 2012; 2012():916198. PubMed ID: 22966451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
    Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis.
    Kam SM; Singh SP; Upthegrove R
    Early Interv Psychiatry; 2015 Aug; 9(4):279-83. PubMed ID: 24251970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE-ETP study.
    Oluwoye O; Monroe-DeVita M; Burduli E; Chwastiak L; McPherson S; McClellan JM; McDonell MG
    Early Interv Psychiatry; 2019 Feb; 13(1):142-146. PubMed ID: 29356438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Tang JY; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Psychiatry Res; 2013 Oct; 209(3):353-60. PubMed ID: 23473654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis.
    Wright AC; Browne J; Cather C; Meyer-Kalos P; Mueser KT
    Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):765-778. PubMed ID: 35900474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
    Cotton SM; Berk M; Watson A; Wood S; Allott K; Bartholomeusz CF; Bortolasci CC; Walder K; O'Donoghue B; Dean OM; Chanen A; Amminger GP; McGorry PD; Burnside A; Uren J; Ratheesh A; Dodd S
    Trials; 2019 Nov; 20(1):658. PubMed ID: 31779696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis.
    Cotton SM; Lambert M; Schimmelmann BG; Foley DL; Morley KI; McGorry PD; Conus P
    Schizophr Res; 2009 Oct; 114(1-3):17-24. PubMed ID: 19635660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis.
    Fraguas D; Merchán-Naranjo J; del Rey-Mejías Á; Castro-Fornieles J; González-Pinto A; Rapado-Castro M; Pina-Camacho L; Díaz-Caneja CM; Graell M; Otero S; Baeza I; Moreno C; Martínez-Cengotitabengoa M; Rodríguez-Toscano E; Arango C; Parellada M
    Schizophr Res; 2014 Sep; 158(1-3):126-33. PubMed ID: 25034759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program.
    Pardo-de-Santayana G; Vázquez-Bourgon J; Gómez-Revuelta M; Ayesa-Arriola R; Ortiz-Garcia de la Foz V; Crespo-Facorro B; Pelayo-Terán JM;
    Data Brief; 2020 Jun; 30():105599. PubMed ID: 32395579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in first-episode psychosis and in people at ultra-high risk.
    Cocchi A; Lora A; Meneghelli A; La Greca E; Pisano A; Cascio MT; Preti A; ;
    Psychiatry Res; 2014 Feb; 215(2):314-22. PubMed ID: 24355686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
    Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
    Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.